[CALT] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
25-Apr-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- -1,240.16%
YoY- -31.27%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 295,481 191,352 49,734 0 474 0 0 -
PBT -247,324 -208,019 -211,434 -136,174 -63,677 -42,556 -38,237 36.46%
Tax -1,164 -20,494 -4,387 -9,305 38 -13 23 -
NP -246,160 -187,525 -207,047 -125,455 -63,715 -42,556 -38,237 36.35%
Tax Rate - - - - - - - -
Total Cost 541,641 378,877 256,781 125,455 64,189 42,556 38,237 55.48%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -83.31 -98.00 -416.31 0.00 -13,441.98 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -9.17 -3.49 -7.91 -5.02 -3.29 -1.21 -2.29 25.98%
EPS Diluted -9.17 -3.49 -7.91 -5.02 -1.92 -1.21 -2.29 25.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.